Compare Enveric Biosciences Inc (ENVB) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Zimmer Biomet Holdings Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2991.9× Enveric Biosciences Inc's market cap, and Zimmer Biomet Holdings Inc pays a 0.99% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | ZBH | |
|---|---|---|
Market Cap | $6.20M | $18.55B |
Sector | Health | Health |
52-Week High | $17.40 | $107.71 |
52-Week Low | $1.27 | $79.58 |
Enterprise Value | $1.30M | $25.61B |
Dividend Yield | — | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
